Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Celon Pharma SA

CLN
Current price
25.9 PLN -0.15 PLN (-0.58%)
Last closed 26.65 PLN
ISIN PLCLNPH00015
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Warsaw Stock Exchange
Capitalization 1 450 920 305 PLN
Yield for 12 month +75.24 %
1Y
3Y
5Y
10Y
15Y
CLN
21.11.2021 - 28.11.2021

Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. operates as a subsidiary of Glatton Sp. z o.o. Address: Ogrodowa 2A, Lomianki, Poland, 05-092

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

94.34 PLN

P/E ratio

Dividend Yield

0.32 %

Current Year

+164 031 647 PLN

Last Year

+161 558 113 PLN

Current Quarter

+53 463 898 PLN

Last Quarter

+34 721 301 PLN

Current Year

+97 359 928 PLN

Last Year

+95 242 604 PLN

Current Quarter

+36 277 862 PLN

Last Quarter

+21 673 124 PLN

Key Figures CLN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -13 581 997 PLN
Operating Margin TTM -10.54 %
PE Ratio
Return On Assets TTM -4.76 %
PEG Ratio
Return On Equity TTM -9.83 %
Wall Street Target Price 94.34 PLN
Revenue TTM 206 352 160 PLN
Book Value 8.98 PLN
Revenue Per Share TTM
Dividend Share 0.08 PLN
Quarterly Revenue Growth YOY -3.4 %
Dividend Yield 0.32 %
Gross Profit TTM 133 516 058 PLN
Earnings per share -0.87 PLN
Diluted Eps TTM -0.87 PLN
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -21.99 %

Dividend Analytics CLN

Dividend growth over 5 years

-47 %

Continuous growth

Payout Ratio 5 years average

5 %

Dividend History CLN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.08
Ex Dividend Date 27.06.2024
Forward Annual Dividend Yield 0.3 %
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CLN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 7.8599
Price Sales TTM 7.0313
Enterprise Value EBITDA 92.8763
Price Book MRQ 3.1655

Financials CLN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CLN

For 52 weeks

13.9 PLN 32.83 PLN
50 Day MA 28.32 PLN
Shares Short Prior Month
200 Day MA 20.94 PLN
Short Ratio
Shares Short
Short Percent